#United States #New York #Gross Law Firm #Savara Inc #SVRA

Important Notice for Savara Inc. Investors

On September 29, 2025, The Gross Law Firm issued a crucial statement for shareholders of Savara Inc. (NASDAQ: SVRA), reminding them of an impending class action lawsuit. This notice is of particular importance for investors who acquired shares during the designated class period, which runs from March 4, 2024, to May 23, 2025. If you were involved in this timeframe, the firm encourages your proactive engagement with them about the possibility of being appointed as a lead plaintiff.

What is a Lead Plaintiff?

Being a lead plaintiff means representing the group of shareholders in the class action lawsuit, essentially leading the legal effort against the alleged wrongdoings by the defendants. However, it is essential to note that you do not need to be appointed as a lead plaintiff to receive any recovery from the case, which alleviates some pressure from potential participants.

Allegations Against Savara Inc.

The lawsuit arises from allegations that Savara made several materially false and misleading statements during the class period. Key points of contention include:
1. MOLBREEVI BLA's Approval Process: Defendants allegedly failed to disclose vital information regarding the chemistry and manufacturing controls surrounding MOLBREEVI, an investigational treatment for pulmonary alveolar proteinosis (PAP).
2. FDA Approval Concerns: It is asserted that there was a substantial likelihood that the FDA would not approve the MOLBREEVI BLA in its present form due to lack of sufficient information, which could impact the company’s ability to meet its previously stated timeline for submission.
3. Need for Additional Capital: Investors were allegedly misled about the need for Savara to secure additional funding as a result of delays in getting the necessary regulatory approvals.
4. Misleading Public Statements: All these misrepresented conditions rendered the defendants' public statements false and misleading at every relevant juncture.

Key Deadlines

Investors should be aware of the urgent deadlines associated with this case. The last day to register as a lead plaintiff is November 7, 2025. Given the timeline, potential claimants are advised to act swiftly to secure their positions before this deadline.

Next Steps for Interested Investors

If you believe you are affected by this situation, the registration process is straightforward. By visiting the link provided in the original notice, you can submit your information as a shareholder who holds, or held, shares during the specified time. Once your registration is confirmed, you will gain access to a portfolio monitoring service that will keep you updated on the case's progress. Importantly, participating in this class action carries no costs or obligations for you.

Why Choose the Gross Law Firm?

The Gross Law Firm is respected nationally, recognized for its dedication to safeguarding investor rights against fraudulent and deceptive corporate practices. Their commitment stands firm in advocating for responsible corporate governance and assuring that companies conduct business ethically. Investors are encouraged to understand that while past outcomes do not guarantee future success, the firm’s reputation offers assurance of diligent representation during this pivotal process.

For inquiries or more information, stakeholders can reach The Gross Law Firm via email or phone.

Contact Information:

• - Address: 15 West 38th Street, 12th Floor, New York, NY, 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

Act promptly to ensure your interests are well represented in this significant legal matter surrounding Savara Inc. Be informed, be proactive, and don’t miss your chance to participate in this class action lawsuit.